Skip to main content
. 2020 Jun 15;9(6):1870. doi: 10.3390/jcm9061870

Figure 1.

Figure 1

Genomic-informed and immunotherapy-focused management of NSCLC based on approved therapies. The role of immunotherapy is not clear in all of the actionable targets but is currently under investigation.